ArticleBMJ supportive & palliative care2021
Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network.
Article in BMJ supportive & palliative care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Preferred Place of Death in Adult Cancer Patients: A Systematic Review and Meta-Analysis.Frontiers in psychology · 2021Pooled it
- Levels and Determinants of Place-Of-Death Congruence in Palliative Patients: A Systematic Review.Frontiers in psychology · 2021Pooled it
- Changes in Home-visit Care Utilization and Outcomes During the Coronavirus Disease 2019 Pandemic: Comparison Between Patients With and Without Cancer.Journal of epidemiology · 2026Observational
- Article
- Challenges in hospice and end-of-life care in the transfusion-dependent patient.Hematology. American Society of Hematology. Education Program · 2024Review
- Quality of end-of-life care in patients with hematological malignancies: potential role of palliative care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Observational
- Characteristics of cancer patients dying at home during the COVID-19 pandemic: A study based on vital statistics from 2015 to 2022 in Japan.Journal of general and family medicine · 2024Article
- Place of Death for Adults Receiving Specialist Palliative Care in Their Last 3 Months of Life: Factors Associated With Preferred Place, Actual Place, and Place of Death Congruence.Journal of palliative care · 2024Article
- Relationships between bereaved families' decision-making regret about end-of-life care place for patients with cancer and relevant factors.Asia-Pacific journal of oncology nursing · 2023Article
- End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital.Palliative medicine reports · 2023Article
- Home or hospital as the place of end-of-life care and death: A survey among Chinese residents of Macao.Frontiers in public health · 2023Article
- Sequencing therapy in relapsed DLBCL.Hematology. American Society of Hematology. Education Program · 2022Article
- Physicians' Conceptions of the Dying Patient: Scoping Review and Qualitative Content Analysis of the United Kingdom Medical Literature.Qualitative health research · 2022Article
- Intensity of care in cancer patients in the last year of life: a retrospective data linkage study.British journal of cancer · 2022Article
- Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.International journal of epidemiology · 2022Article
- Where Are We Dying? Ethnic Differences in Place of Death Among New Zealanders Dying of Cancer.JCO global oncology · 2022Article
- Preferred place of death and end-of-life care for adult cancer patients in Iran: A cross-sectional study.Frontiers in oncology · 2022Article
- Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?Current hematologic malignancy reports · 2021Review
- Where Do Cancer Patients in Receipt of Home-Based Palliative Care Prefer to Die and What Are the Determinants of a Preference for a Home Death?International journal of environmental research and public health · 2020Article
- Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas.Hematology. American Society of Hematology. Education Program · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
Abstract
objectivesHospital death is comparatively common in people with haematological cancers, but little is known about patient preferences. This study investigated actual and preferred place of death, concurrence between these and characteristics of preferred place discussions.
methodsSet within a population-based haematological malignancy patient cohort, adults (≥18 years) diagnosed 2004-2012 who died 2011-2012 were included (n=963). Data were obtained via routine linkages (date, place and cause of death) and abstraction of hospital records (diagnosis, demographics, preferred place discussions). Logistic regression investigated associations between patient and clinical factors and place of death, and factors associated with the likelihood of having a preferred place discussion.
resultsOf 892 patients (92.6%) alive 2 weeks after diagnosis, 58.0% subsequently died in hospital (home, 20.0%; care home, 11.9%; hospice, 10.2%). A preferred place discussion was documented for 453 patients (50.8%). Discussions were more likely in women (p=0.003), those referred to specialist palliative care (p
conclusionChallenges remain in ensuring that patients are supported to have meaningful end-of-life discussions, with healthcare services that are able to respond to changing decisions over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.